In preclinical models, MET gene amplification results in constitutive activation of the MET receptor and an oncogenic addiction to the MET signaling pathway thereby rendering gastric tumor cells acutely sensitive to HGF/MET axis inhibition [40, 41]. Here, HGF is linked to gastric neoplasm.